NIH-funded research R21 grant

Investigating how sex differences affect brain cells linked to Autism Spectrum Disorder.

Official title: Sex dependent dysregulation of parvalbumin interneurons as a pathway to Autism Spectrum Disorder

Funded at Feinstein Institute for Medical Research · NIH-11057198 · Data updated 2026-11-12

This study is looking at how certain brain cells might be involved in Autism Spectrum Disorder and how they could be affected differently in boys and girls, especially when mothers have specific antibodies during pregnancy, to help find new ways to support those with ASD.

More Autism research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionFeinstein Institute for Medical Research
NIH-funded
Lab location1 site (Manhasset, United States)
Project startSeptember 23, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$251,250
NIH project number1R21MH136489-01A1
Project IDNIH-11057198 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include children diagnosed with Autism Spectrum Disorder and their mothers.

Less likely to help

Patients who do not have Autism Spectrum Disorder or are not related to affected individuals may not receive any benefit from this research.

What this research studies

This research explores the role of specific brain cells called parvalbumin interneurons in the development of Autism Spectrum Disorder (ASD), focusing on how these cells may be affected differently in males and females. The study examines the impact of maternal antibodies on these brain cells during pregnancy, particularly looking at a protein called Caspr2 that is linked to ASD. By using animal models, the researchers aim to understand the biological mechanisms that may lead to ASD, which could help identify potential interventions or treatments.

Why it matters

Potential benefit: If successful, this research could lead to new insights into the causes of Autism Spectrum Disorder and pave the way for targeted therapies.

How similar studies have gone: Previous research has indicated that understanding the role of specific brain cells in ASD can lead to significant advancements in treatment, suggesting this approach has potential for success.

Where this research is happening

  • Feinstein Institute for Medical Research
    Manhasset, United States
    Active

Researchers

  • Principal investigator: Brimberg, Lior — Feinstein Institute for Medical Research
  • Study coordinator: Brimberg, Lior

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.